| Literature DB >> 35312860 |
Ivana Rabbone1, Silvia Savastio1, Ciro Pigniatiello1, Chiara Carducci2, Maria Giulia Berioli3, Valentino Cherubini4, Donatella Lo Presti5, Giulio Maltoni6, Chiara Mameli7, Marco Marigliano8, Nicola Minuto9, Enza Mozzillo10, Elvira Piccinno11, Barbara Predieri12, Andrea Rigamonti13, Carlo Ripoli14, Riccardo Schiaffini2, Fortunato Lombardo15, Davide Tinti16, Sonia Toni17, Angela Zanfardino18, Andrea Enzo Scaramuzza19.
Abstract
OBJECTIVE: To evaluate the six-month impact of the advanced automated functions of a closed-loop control (CLC) system (Control-IQ) and a virtual educational camp (vEC) on emotions and time in range (TIR) of children and adolescents with type 1 diabetes.Entities:
Keywords: Adolescents; Advanced hybrid closed loop; Children; Closed-loop control; Emotions; Type 1 diabetes; Virtual educational camp
Mesh:
Substances:
Year: 2022 PMID: 35312860 PMCID: PMC8935105 DOI: 10.1007/s00592-022-01878-z
Source DB: PubMed Journal: Acta Diabetol ISSN: 0940-5429 Impact factor: 4.087
Fig. 1Frequency of positive and mixed emotions evaluated after upgrading the CLC from the Basal-IQ to Control-IQ algorithm, before vEC, just after the vEC, and six months after the vEC. No children expressed all negative emotions only
Frequency of the emotions described using a modified Plutchik’s Wheel of Emotions and the Geneva Emotion Wheel, just before, at the end, and six months after the virtual Educational Camp (vEC)
| Baseline (%) | After vEC (%) | Six months after vEC (%) | |
|---|---|---|---|
| Anger | 17.3 | 3.8 | 2.7 |
| Joy | 75.9 | 76.9 | 77.6 |
| Fear | 27.6 | 11.5 | 5.3 |
| Calm | 65.5 | 76.9 | 77.1 |
| Envy | 7.3% | 1.8 | 1.9 |
| Surprise | 24.1 | 26.9 | 25.8 |
| Sadness | 6.5% | 6.9 | 5.1 |
| Indifference | 17.2 | 7.7 | 3.8 |
| Satisfaction | 27.6 | 29.9 | 29.4 |
| Disgust | 1 | 0 | 0 |
Overall continuous glucose monitoring (CGM) outcomes measured before updating to the Control-IQ system and six months after the virtual Educational Camp (vEC)
| Baseline* | After 6 months* | Difference# | ||
|---|---|---|---|---|
| % Time < 54 mg/dl | 0 (0; 1) | 0 (0; 1) | 0 (− 1; 1) | 0.588 |
| % Time 54–70 mg/dl | 1 (1; 2) | 2 (1; 3) | 1 (− 1; 1) | 0.334 |
| % Time 70–180 mg/dl | 64 (54; 72) | 75 (70; 82) | 11 (9; 14) | < 0.001 |
| % Time 180–250 mg/dl | 26 (20; 28) | 18 (13; 22) | − 8 (− 7; − 4) | < 0.001 |
| % Time > 250 mg/dl | 8 (4; 15) | 3 (2; 6) | − 5 (− 6; − 3) | < 0.001 |
| % CGM active | 96 (88; 98) | 97 (92; 98) | 1 (− 1; 3) | 0.673 |
| Mean BG | 162 (145; 176) | 147 (135; 157) | − 15 (− 19; − 9) | < 0.001 |
| %CV | 36 (33; 38) | 32 (30; 36) | − 4 (− 6; − 2) | 0.001 |
| GMI | 7.2 (6.8; 7.5) | 6.8 (6.5; 7.1) | − 0.4 (− 0.5; − 0.2) | 0.001 |
*Values are presented as median (IQR)
#Differences are baseline vs. after 6-month values and presented as median (95% CI)
CGM outcome p values refer to the Wilcoxon signed–rank test; BG, blood glucose; CV, coefficient of variation; GMI, glucose management indicator